Sector
PharmaceuticalsOpen
₹0.15Prev. Close
₹0.15Turnover(Lac.)
₹0.45Day's High
₹0.2Day's Low
₹0.152 Week's High
₹052 Week's Low
₹0Book Value
₹-38.52Face Value
₹1Mkt Cap (₹ Cr.)
3.04P/E
0.01EPS
12.76Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 |
|---|---|---|---|---|
Equity Capital | 20.28 | 20.28 | 25.84 | 14.47 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -74.61 | 227.2 | 494.11 | 288.72 |
Net Worth | -54.33 | 247.48 | 519.95 | 303.19 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Revenue | 60.33 | 1,622.94 | 1,600.41 |
yoy growth (%) | -96.28 | 1.4 | |
Raw materials | -182.85 | -1,654.5 | -1,230.99 |
As % of sales | 303.09 | 101.94 | 76.91 |
Employee costs | -8.84 | -40.91 | -40.35 |
| Y/e 31 Mar( In .Cr) | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Profit before tax | -440.77 | -393.22 | 131.71 |
Depreciation | -62.46 | -34.61 | -26.54 |
Tax paid | 156.89 | 120.06 | -31.55 |
Working capital | -144.38 | -295.48 | |
Other operating items |
| Y/e 31 Mar | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -96.28 | 1.4 | |
Op profit growth | 1.42 | -161.08 | |
EBIT growth | 4.27 | -199.07 | |
Net profit growth | 10.49 | -376.16 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,687.6 | 94.57 | 4,05,007.74 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,658 | 80.01 | 1,76,747.65 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,502.4 | 25.22 | 1,21,378.29 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,341.4 | 59.4 | 1,13,184.61 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,301 | 20.3 | 1,08,591.61 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Alka Goyal
Chairman & Managing Director
Rajiv Goyal
Additional Director
Jasvinder Singh
1596 1st Floor,
Bhagirath Palace,
Delhi - 110006
Tel: -
Website: http://www.suryapharma.com
E-2/3 Saki Vihar Rd,
Ansa Indl Estate, Saki Naka Andheri-E,
Mumbai - 400 072
Tel: 91-22-40430200
Website: www.bigshareonline.com
Email: [email protected]
Summary
Surya Pharmaceuticals (Surya) is a Chandigarh-based pharmaceutical company with four manufacturing facilities spread across three states of Himachal Pradesh, Haryana and Punjab. The company produces s...
Read More
Reports by Surya Pharmaceutical Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.